ADAMTS13 and thrombotic thrombocytopenic purpura: We hypothesized that providing mRNA-encoded ADAMTS13 would provide a steady supply of secreted, therapeutic protein for at least a few days and may be useful in treating patients even prior to a differential diagnosis of TTP or aHUS.